Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

EBOS Group Limited

EBOSYPNK
Healthcare
Medical - Specialties
$35.03
$0.00(0.00%)
U.S. Market opens in 10h 53m

EBOS Group Limited Fundamental Analysis

EBOS Group Limited (EBOSY) shows weak financial fundamentals with a PE ratio of 12.44, profit margin of 1.76%, and ROE of 6.22%. The company generates $8.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position11.44%
PEG Ratio-0.80

Areas of Concern

ROE6.22%
Operating Margin3.46%
We analyze EBOSY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 41.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
41.4/100

We analyze EBOSY's fundamental strength across five key dimensions:

Efficiency Score

Weak

EBOSY struggles to generate sufficient returns from assets.

ROA > 10%
1.78%

Valuation Score

Excellent

EBOSY trades at attractive valuation levels.

PE < 25
12.44
PEG Ratio < 2
-0.80

Growth Score

Moderate

EBOSY shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

EBOSY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.59
Current Ratio > 1
1.18

Profitability Score

Weak

EBOSY struggles to sustain strong margins.

ROE > 15%
6.22%
Net Margin ≥ 15%
1.76%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is EBOSY Expensive or Cheap?

P/E Ratio

EBOSY trades at 12.44 times earnings. This suggests potential undervaluation.

12.44

PEG Ratio

When adjusting for growth, EBOSY's PEG of -0.80 indicates potential undervaluation.

-0.80

Price to Book

The market values EBOS Group Limited at 0.59 times its book value. This may indicate undervaluation.

0.59

EV/EBITDA

Enterprise value stands at 0.65 times EBITDA. This is generally considered low.

0.65

How Well Does EBOSY Make Money?

Net Profit Margin

For every $100 in sales, EBOS Group Limited keeps $1.76 as profit after all expenses.

1.76%

Operating Margin

Core operations generate 3.46 in profit for every $100 in revenue, before interest and taxes.

3.46%

ROE

Management delivers $6.22 in profit for every $100 of shareholder equity.

6.22%

ROA

EBOS Group Limited generates $1.78 in profit for every $100 in assets, demonstrating efficient asset deployment.

1.78%

Following the Money - Real Cash Generation

Operating Cash Flow

EBOS Group Limited generates limited operating cash flow of $272.39M, signaling weaker underlying cash strength.

$272.39M

Free Cash Flow

EBOS Group Limited generates weak or negative free cash flow of $190.94M, restricting financial flexibility.

$190.94M

FCF Per Share

Each share generates $3.76 in free cash annually.

$3.76

FCF Yield

EBOSY converts 10.45% of its market value into free cash.

10.45%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

12.44

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.80

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.59

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.22

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.59

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.18

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.06

vs 25 benchmark

ROA

Return on assets percentage

0.02

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How EBOSY Stacks Against Its Sector Peers

MetricEBOSY ValueSector AveragePerformance
P/E Ratio12.4429.45 Better (Cheaper)
ROE6.22%779.00% Weak
Net Margin1.76%-24936.00% (disorted) Weak
Debt/Equity0.590.26 Weak (High Leverage)
Current Ratio1.184.65 Neutral
ROA1.78%-19344.00% (disorted) Weak

EBOSY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews EBOS Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ